
Sign up to save your podcasts
Or


Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
By John Simboli5
77 ratings
Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.

3,062 Listeners

1,938 Listeners

1,094 Listeners

2,362 Listeners

946 Listeners

793 Listeners

123 Listeners

321 Listeners

6,066 Listeners

94 Listeners

10,024 Listeners

518 Listeners

153 Listeners

249 Listeners

182 Listeners